Poor prognosis acute myelogenous leukemia: 1 - response to treatment with high dose cytarabine/mitoxantrone/ethyol @ (Amifostine).

H D Preisler; P Venugopal; S A Gregory; W Hsu; J Loew; S Adler; S Gezer; S Creech; A Galvez; D Slivnick

doi:10.1016/s0145-2126(00)00037-0

Poor prognosis acute myelogenous leukemia: 1 - response to treatment with high dose cytarabine/mitoxantrone/ethyol @ (Amifostine).

Identifier:nobleid.org/w1/20260515/F1DF2DEF

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/F1DF2DEF.svg?ark=w1%2F20260515%2FF1DF2DEF)](https://nobleid.org/work/w1/20260515/F1DF2DEF)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Poor prognosis acute myelogenous leukemia: 1 - response to treatment with high dose cytarabine/mitoxantrone/ethyol @ (Amifostine).

Identifier:nobleid.org/w1/20260515/F1DF2DEF

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/F1DF2DEF.svg?ark=w1%2F20260515%2FF1DF2DEF)](https://nobleid.org/work/w1/20260515/F1DF2DEF)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work